June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Care Coordinations' Effect on Screening for Diabetic Retinopathy
Author Affiliations & Notes
  • Brittany Assanah
    Yale University, New Haven, Connecticut, United States
  • June Weiss
    Yale University, New Haven, Connecticut, United States
  • Akua Frimpong
    University of Vermont Larner College of Medicine, Burlington, Vermont, United States
  • Elijah Demb
    University of Connecticut, Storrs, Connecticut, United States
  • Christina Jayaraj
    Yale University, New Haven, Connecticut, United States
  • Lauren Kelley
    Project Access, New Haven, Connecticut, United States
  • Kristen Harris Nwanyanwu
    Yale University, New Haven, Connecticut, United States
  • Footnotes
    Commercial Relationships   Brittany Assanah None; June Weiss None; Akua Frimpong None; Elijah Demb None; Christina Jayaraj None; Lauren Kelley None; Kristen Nwanyanwu Genetech, Code C (Consultant/Contractor)
  • Footnotes
    Support  This publication was made possible by Grant Number 1 K23 EY030530-01 from the National Eye Institute, Yale Diabetes Center Grant P30 DK045735, and the Doris Duke Fund to Retain Clinical Scientists. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. This work has been supported in part by an unrestricted/challenge award to Yale Eye Center from the Research to Prevent Blindness (RPB), Inc.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2272. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Brittany Assanah, June Weiss, Akua Frimpong, Elijah Demb, Christina Jayaraj, Lauren Kelley, Kristen Harris Nwanyanwu; Care Coordinations' Effect on Screening for Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2272.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Identify care coordination and patient navigation for participants at high risk for diabetic retinopathy (DR).

Methods : The Sight-saving engagement and evaluation in New Haven (SEEN) lab is a care coordination, risk stratification and patient navigation program in coordination with Project Access New Haven. Participants >18 and older are identified via EMR and community events. These potential participants are risk stratified using our COX model algorithm. Participants who are at high risk for DR (the highest quartile) are screened into the pilot program. The program consists of a fundus exam with photography, a comprehensive eye exam, patient education, and patient navigation. Patient navigation is facilitated by Project Access New Haven. Each care coordination encounter is documented by the patient navigator, the study will continue to follow patients for one year with intentional follow up at 3, 6, 9 and 12 months.

Results : To date we have enrolled 7 participants. The average age of our patients is 51. Thus far we have enrolled 29% women, 29 % black, 71% non- Hispanic. The average HbA1c is 9.9. Our average 3-year risk for patients is 0.1951. Our average 5-year risk for patient is 0.2462. We also ran our patients thru the ADA diabetic retinopathy risk calculator, our average patient risk was 4.2. The average amount of times that each patient and patient navigator interacted was 4.3. The average time of each patient encounter was half an hour. (See figure 1).

Conclusions : Care coordination and patient navigation may address social determinants of health and the population that is at high risk of diabetic retinopathy. Patient navigation requires a patient- navigator relationship to be formed and nourished. As these relationship continues to progress patient patient navigation may be a successful tool in helping patients who underutilize a busy medical system get the care they deserve. A larger program maybe a helpful mechanism for evaluating the success of patient navigation in helping those screen high risk for DR.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×